1Anan K, Morisaki T,Katano M, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer[J ]. Surgery, 1996,119(3):333-339.
2Salven P, Perhoniemi V, Tykka H, et al. Serum VEGF levels in women with a benign breat tumor or breast cancer[J]. Breast Cancer Res Treat, 1999,53(2) : 161 - 166.
3Adams J, Carder PJ,Downey S, et al. Vascular endothelial growth factor(VEGF) in breast cancer:Comparison of plasma,serum,and tissue VEGF and microvessel density and effects of tamoxifen[J].Cancer Res,2000,60(ll):2 898-2 905.
4Asano M, Yukita A, Matsumoto T, et al. Inhibition of gumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121[J]. Cancer Res,1995,55(22):5 296-5 301.
5Locopo N, Fanelli M, Gasparini G, et al. Clinical significance of angiogenic factors in breast cancer[J]. Breast Cancer Res Treast,1998,52(1-3):159-173.
6Yoshiji H, Gomez DE, Shibuya M, et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer[J]. Cancer Res, 1996,56(9):2 013-2 016.
7Toi M, Yamamoto Y,Taniguchi T, et al. Regulation of endothelial growth factor expressions in breast cancer[J]. Gan To Kagaku Ryoho, 1996,23 ( Suppl ) : 75 - 79.
8Speirs V, Atkin SL. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours[J]. Br J Cancer,1999,80 (5 - 6) : 898 - 903.
